Hirschfield GM, Karlsen TH, Lindor KD, Adams DH (2013) Primary sclerosing cholangitis. Lancet 382(9904):1587–1599
Lightner AL, Mathis KL, Dozois EJ et al (2017) Results at Up to 30 years after ileal pouch-anal anastomosis for chronic ulcerative colitis. Inflamm Bowel Dis 23(5):781–790
Murphy PBKZ, Vogt KN, Ott M, Dubois L (2015) Quality of life after total proctocolectomy with ileostomy or IPAA: a systematic review. Dis Colon Rectum 58(9):899–908
Kuruvilla K, Osler T, Hyman NH (2012) A comparison of the quality of life of ulcerative colitis patients after IPAA vs ileostomy. Dis Colon Rectum 55(11):1131–1137
Camilleri-Brennan JMA, Steele RJ (2003) Does an ileoanal pouch offer a better quality of life than a permanent ileostomy for patients with ulcerative colitis? J Gastrointest Surg 7(6):814–819
Trivedi PJ, Reece J, Laing RW et al (2018) The impact of ileal pouch-anal anastomosis on graft survival following liver transplantation for primary sclerosing cholangitis. Aliment Pharmacol Ther 48(3):322–332
Article CAS PubMed Google Scholar
Obusez EC, Lian L, Shao Z et al (2013) Impact of ileal pouch-anal anastomosis on the surgical outcome of orthotopic liver transplantation for primary sclerosing cholangitis. J Crohns Colitis 7(3):230–238
Maspero M, Holubar SD, Raj R et al (2023) Ileal Pouch-anal anastomosis in primary sclerosing cholangitis-inflammatory bowel disease (PSC-IBD): long-term pouch and liver transplant outcomes. Ann Surg 278(6):961–968
Alabraba E, Nightingale P, Gunson B et al (2009) A re-evaluation of the risk factors for the recurrence of primary sclerosing cholangitis in liver allografts. Liver Transpl 15(3):330–340
Joshi D, Bjarnason I, Belgaumkar A et al (2013) The impact of inflammatory bowel disease post-liver transplantation for primary sclerosing cholangitis. Liver Int 33(1):53–61
Yoshida H, Granger DN (2009) Inflammatory bowel disease: a paradigm for the link between coagulation and inflammation. Inflamm Bowel Dis 15(8):1245–1255
Shen B (2012) Acute and chronic pouchitis–pathogenesis, diagnosis and treatment. Nat Rev Gastroenterol Hepatol 9(6):323–333
Article CAS PubMed Google Scholar
Martin EF, Levy C (2017) Timing, management, and outcomes of liver transplantation in primary sclerosing cholangitis. Semin Liver Dis 37(4):305–313
Sharma S, Gurakar A, Jabbour N (2008) Biliary strictures following liver transplantation: past, present and preventive strategies. Liver Transpl 14(6):759–769
Hildebrand T, Pannicke N, Dechene A et al (2016) Biliary strictures and recurrence after liver transplantation for primary sclerosing cholangitis: a retrospective multicenter analysis. Liver Transpl 22(1):42–52
Mathis KL, Dozois EJ, Larson DW et al (2008) Ileal pouch-anal anastomosis and liver transplantation for ulcerative colitis complicated by primary sclerosing cholangitis. Br J Surg 95(7):882–886
Article CAS PubMed Google Scholar
Oldakowska-Jedynak U, Nowak M, Mucha K et al (2006) Recurrence of primary sclerosing cholangitis in patients after liver transplantation. Transplant Proc 38(1):240–243
Article CAS PubMed Google Scholar
Cho CS, Dayton MT, Thompson JS, Koltun WA, Heise CP, Harms BA (2008) Proctocolectomy-ileal pouch-anal anastomosis for ulcerative colitis after liver transplantation for primary sclerosing cholangitis: a multi-institutional analysis. J Gastrointest Surg 12(7):1221–1226
Moncrief KJSA, Ma MM, Bain VG, Wong WW, Tandon P (2010) The natural history of inflammatory bowel disease and primary sclerosing cholangitis after liver transplantation–a single-centre experience. Can J Gastroenterol 24(1):40–46
Article PubMed PubMed Central Google Scholar
Visseren T, Erler NS, Polak WG et al (2021) Recurrence of primary sclerosing cholangitis after liver transplantation-analysing the European liver transplant registry and beyond. Transpl Int 34(8):1455–1467
Ravikumar R, Tsochatzis E, Jose S et al (2015) Risk factors for recurrent primary sclerosing cholangitis after liver transplantation. J Hepatol 63(5):1139–1146
Peverelle M, Paleri S, Hughes J, De Cruz P, Gow PJ (2020) Activity of inflammatory bowel disease after liver transplantation for primary sclerosing cholangitis predicts poorer clinical outcomes. Inflamm Bowel Dis 26(12):1901–1908
Thurairajah PH, Carbone M, Bridgestock H et al (2013) Late acute liver allograft rejection; a study of its natural history and graft survival in the current era. Transplantation 95(7):955–959
Soetikno RM, Lin OS, Heidenreich PA, Young HS, Blackstone MO (2002) Increased risk of colorectal neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis: a meta-analysis. Gastrointest Endosc 56(1):48–54
Bergquist AEA, Olsson R, Kornfeldt D, Lööf L, Danielsson A, Hultcrantz R, Lindgren S, Prytz H, Sandberg-Gertzén H, Almer S, Granath F, Broomé U (2002) Hepatic and extrahepatic malignancies in primary sclerosing cholangitis. J Hepatol 36(3):321–327
Trivedi PJ, Crothers H, Mytton J et al (2020) Effects of primary sclerosing cholangitis on risks of cancer and death in people with inflammatory bowel disease, based on sex, race, and age. Gastroenterology 159(3):915–928
Byrne CM, Tan KK, Young JM, Selby W, Solomon MJ (2014) Patient and clinician preferences for surgical and medical treatment options in ulcerative colitis. Colorectal Dis 16(4):285–292
Article CAS PubMed Google Scholar
Malinchoc M, Kamath PS, Gordon FD, Peine CJ, Rank J, ter Borg PC (2000) A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology 31(4):864–871
留言 (0)